Literature DB >> 748390

Frequency distribution and 'reference values' of plasma alkaline phosphatase (EC 3.1.3.1) activity in the adult population of a Scottish new town.

M D Gardner, R Scott.   

Abstract

As part of a study to establish the prevalence of renal calculus disease, alkaline phosphatase activity was measured by the method recommended by the Scandinavian Society for Clinical Chemistry and Clinical Physiology in the plasma of 3823 adults from the Scottish new town of Cumbernauld. The enzyme activity differs in males and females and increases with age. Reference ranges are presented.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 748390      PMCID： PMC1145531          DOI： 10.1136/jcp.31.12.1202

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  14 in total

1.  Activities of aspartate and alanine aminotransferases and alkaline phosphatase in sera of healthy subjects.

Authors:  I M Penttilä; H A Jokela; A J Viitala; E Heikkinen; S Nummi; P Pystynen; J Saastamoinen
Journal:  Scand J Clin Lab Invest       Date:  1975-05       Impact factor: 1.713

2.  Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values.

Authors:  G Siest; F Schiele; M M Galteau; E Panek; J Steinmetz; F Fagnani; R Gueguen
Journal:  Clin Chem       Date:  1975-07       Impact factor: 8.327

3.  Technical bulletin No. 35. Investigation of the validity of temperature correction factors for serum aspartate and alanine transaminases.

Authors:  S B Rosalki; S S Brown; A Fleck; J J McCormack; G R Padmore; A F Smith; J H Wilkinson
Journal:  Ann Clin Biochem       Date:  1975-03       Impact factor: 2.057

4.  Activities of bone and liver alkaline phosphatases in serum in health and disease.

Authors:  K B Whitaker; L G Whitby; D W Moss
Journal:  Clin Chim Acta       Date:  1977-10-01       Impact factor: 3.786

5.  The frequency distributions of commonly determined blood constituents in healthy blood donors.

Authors:  F V Flynn; K A Piper; P Garcia-Webb; K McPherson; M J Healy
Journal:  Clin Chim Acta       Date:  1974-04       Impact factor: 3.786

6.  Patterns of change for various biochemical constituents detected in well population screening.

Authors:  P Wilding; J G Rollason; D Robinson
Journal:  Clin Chim Acta       Date:  1972-10       Impact factor: 3.786

7.  A comparison of conventionally derived normal ranges WITH THOSE OBTAINED FROM PATIENTS' results.

Authors:  M W O'Halloran; J Studley-Ruxton; M L Wellby
Journal:  Clin Chim Acta       Date:  1970-01       Impact factor: 3.786

8.  Development of normal values for use in multitest biochemical screening of sera.

Authors:  R T O'Kell; J R Elliott
Journal:  Clin Chem       Date:  1970-03       Impact factor: 8.327

9.  Estimation of normal ranges from a controlled sample survey. I. Sex- and age-related influence on the SMA 12-60 screening group of tests.

Authors:  A H Reed; D C Cannon; J W Winkelman; Y P Bhasin; R J Henry; V J Pileggi
Journal:  Clin Chem       Date:  1972-01       Impact factor: 8.327

10.  The prevalence of calcified upper urinary tract stone disease in a random population--Cumbernauld Health Survey.

Authors:  R Scott; R Freeland; W Mowat; M Gardiner; V Hawthorne; R M Marshall; J G Ives
Journal:  Br J Urol       Date:  1977
View more
  3 in total

1.  Serum alkaline phosphatase in ankylosing spondylitis.

Authors:  D H Smith; D G Spencer; B F Allam; E Farish; W W Borland
Journal:  J Clin Pathol       Date:  1979-08       Impact factor: 3.411

2.  Age- and sex-related reference ranges for eight plasma constituents derived from randomly selected adults in a Scottish new town.

Authors:  M D Gardner; R Scott
Journal:  J Clin Pathol       Date:  1980-04       Impact factor: 3.411

3.  Serum gamma-glutamyltransferase and alkaline phosphatase in rheumatoid arthritis.

Authors:  R J Spooner; D H Smith; D Bedford; P R Beck
Journal:  J Clin Pathol       Date:  1982-06       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.